Article
Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.
Circulation - 2 Jul 2002
Priori Silvia G, Napolitano Carlo, Memmi Mirella, Colombi Barbara, Drago Fabrizio, Gasparini Maurizio, DeSimone Luciano, Coltorti Fernando, Bloise Raffaella, Keegan Roberto, Cruz Filho Fernando E S, Vignati Gabriele, Benatar Abraham, DeLogu Angelica
Abstract excerpt
BACKGROUND: Mutations in the cardiac ryanodine receptor gene (RyR2) underlie catecholaminergic polymorphic ventricular tachycardia (CPVT), an inherited arrhythmogenic disease occurring in the structurally intact heart. The proportion of patients with CPVT carrying RyR2 mutations is unknown, and t...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.